✦ LIBER ✦
The Addition of Bevacizumab (BEV) to Temozolomide (TMZ) and Radiation Therapy (RT) in Newly Diagnosed Glioblastoma (GBM) Improves Progression-Free Survival (PFS) Without Adding to RT Toxicity
✍ Scribed by Saran, F.; Henriksson, R.; Mason, W.; Wick, W.; Nishikawa, R.; Cloughesy, T.; Hilton, M.; Kerloeguen, Y.; Chinot, O.L.
- Book ID
- 122673952
- Publisher
- Elsevier Science
- Year
- 2013
- Tongue
- English
- Weight
- 45 KB
- Volume
- 87
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.